NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Mindray A7 Anesthesia Workstation with Optimizer

The new A7 Anesthesia Workstation takes the well-received A-Series to a higher level. The feature-rich A7 combines advanced ventilation with electronic fresh gas technology and Optimizer functionality to provide effective care across a wide range of patients. Electronic fresh gas control ensures precise, accurate and responsive flow dynamics while the Optimizer provides low flow and inhalation agent management tools to support hospital initiatives to improve clinical outcomes and reduce costs. Real time agent usage calculation, advanced ventilation modes, integrated suction, auxiliary common gas outlet, and a convenient pull out table, provide the necessary tools for today’s clinical and cost-saving requirements. With built-in HL7 connectivity to AIMS and EMR systems and an industry-leading three-year warranty, the A7 functions as a truly comprehensive workstation that saves time, space and cost.

View the Market Analysis

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X